From Risk Assessment to Management: Cardiovascular Complications in Pre- and Post-Kidney Transplant Recipients: A Narrative Review
Diagnostics · 21.03.2025 · 15 (7) · 802
DOI: 10.3390/diagnostics15070802 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Diagnostics, online erschienen am 21.03.2025. Verfasst von Thomas Beaudrey und 4 weiteren Autor:innen. Beteiligte Einrichtung: Nephrology Department, Hôpitaux Universitaires de Strasbourg, 67000 Strasbourg, France. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 257 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kidney transplantation remains the best treatment for chronic kidney failure, offering better outcomes and quality of life compared with dialysis. Cardiovascular disease (CVD) is a major cause of morbidity and mortality in kidney transplant recipients and is associated with decreased patient survival and worse graft outcomes. Post-transplant CVD results from a complex interaction between traditional cardiovascular risk factors, such as hypertension and diabetes, and risk factors specific to kidney transplant recipients including chronic kidney disease, immunosuppressive drugs, or vascular access. An accurate assessment of cardiovascular risk is now needed to optimize the management of cardiovascular comorbidities through the detection of risk factors and the screening of hidden pretransplant coronary artery disease. Promising new strategies are emerging, such as GLP-1 receptor agonists and SGLT2 inhibitors, with a high potential to mitigate cardiovascular complications, although further research is needed to determine their role in kidney transplant recipients. Despite this progress, a significant gap remains in understanding the optimal management of post-transplant CVD, especially coronary artery disease, stroke, and peripheral artery disease. Addressing these challenges is essential to improve the short- and long-term outcomes in kidney transplant recipients. This narrative review aims to provide a comprehensive overview of cardiovascular risk assessment and post-transplant CVD management.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Nephrology Department, Hôpitaux Universitaires de Strasbourg, 67000 Strasbourg, France.
- Inserm UMR_S 1109 Immuno-Rhumatology Laboratory, Translational Medicine Federation of Strasbourg (FMTS), FHU Target, Faculté de Médecine, Université de Strasbourg, 67000 Strasbourg, France.
- INI-CRCT (Cardiovascular and Renal Trialists), F-CRIN Network, 67000 Strasbourg, France.
ORCID-Profile: Thomas Beaudrey, Célia Weschler, Nans Florens
Zitieren
APA
Beaudrey, T., Bedo, D., Weschler, C., Caillard, S., & Florens, N. (2025). From Risk Assessment to Management: Cardiovascular Complications in Pre- and Post-Kidney Transplant Recipients: A Narrative Review. Diagnostics, 15(7), 802. https://doi.org/10.3390/diagnostics15070802
Vancouver
Beaudrey T, Bedo D, Weschler C, Caillard S, Florens N. From Risk Assessment to Management: Cardiovascular Complications in Pre- and Post-Kidney Transplant Recipients: A Narrative Review. Diagnostics. 2025;15(7):802. doi:10.3390/diagnostics15070802
BibTeX
@article{Beaudrey2025,
author = {Beaudrey, Thomas and Bedo, Dimitri and Weschler, Célia and Caillard, Sophie and Florens, Nans},
title = {From Risk Assessment to Management: Cardiovascular Complications in Pre- and Post-Kidney Transplant Recipients: A Narrative Review},
journal = {Diagnostics},
year = {2025},
volume = {15},
number = {7},
pages = {802},
doi = {10.3390/diagnostics15070802}
}
EUVIMED